Divis Laboratories Ltd | DIVI - Cost Of Sales


Divis Laboratories Ltd reported INR12.39B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Alaunos Therapeutics USD 0 18K Sep/2024
Aurobindo Pharma INR 39.08B 383M Mar/2026
Avita Medical AUD 3.3M 166K Dec/2025
Divis Laboratories Ltd INR 12.39B 1.76B Mar/2026
Ionis Pharmaceuticals USD 3M 5M Mar/2026
IQVIA Holdings USD 3.08B 161M Mar/2026
Lupin INR 22.98B 1.07B Mar/2026
Moderna USD 955M 503M Mar/2026
Organon & Co USD 677M 89M Mar/2026
Revvity USD 323.46M 26.93M Mar/2026
Tilray USD 164.37M 8.41M Sep/2025
Viatris USD 2.36B 195.9M Mar/2026
Xeris Pharmaceuticals USD 10.57M 3.08M Mar/2026